Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama

View ORCID ProfileAlcibiades Villarreal, Giselle Rangel, Xu Zhang, Digna Wong, View ORCID ProfileGabrielle Britton, View ORCID ProfilePatricia L. Fernandez, View ORCID ProfileAmbar Pérez, Diana Oviedo, Carlos Restrepo, View ORCID ProfileMaría B. Carreirra, View ORCID ProfileDilcia Sambrano, Gilberto Eskildsen, View ORCID ProfileCarolina De La Guardia, Yamitzel Zaldivar, Danilo Franco, View ORCID ProfileSandra López-Vergès, View ORCID ProfileDexi Zhang, Fanjing Fan, Baojun Wang, View ORCID ProfileXavier Sáez-Llorens, View ORCID ProfileRodrigo DeAntonio, View ORCID ProfileIvonne Torres-Atencio, View ORCID ProfileEduardo Ortega-Barria, View ORCID ProfileRao Kosagisharaf, View ORCID ProfileRicardo Lleonart, Li Chong, View ORCID ProfileAmador Goodridge, COVID-19 serology collaborator group
doi: https://doi.org/10.1101/2020.09.25.20201459
Alcibiades Villarreal
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alcibiades Villarreal
Giselle Rangel
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu Zhang
2Institute of Biophysics, Chinese Academy of Sciences, Beijing, CHINA
3Beijing ZhongkeJianlan Biotechnology Co., Ltd.; Beijing, CHINA
4Zhongke Jianlan International Medical Research Institute, Melbourne, Victoria, AUSTRALIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Digna Wong
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabrielle Britton
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabrielle Britton
Patricia L. Fernandez
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricia L. Fernandez
Ambar Pérez
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ambar Pérez
Diana Oviedo
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Restrepo
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María B. Carreirra
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María B. Carreirra
Dilcia Sambrano
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dilcia Sambrano
Gilberto Eskildsen
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina De La Guardia
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolina De La Guardia
Yamitzel Zaldivar
5Department of Research in Surveillance and Biologic risk 3, Gorgas Memorial Institute of Health Studies, Panama, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danilo Franco
6Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra López-Vergès
6Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sandra López-Vergès
Dexi Zhang
2Institute of Biophysics, Chinese Academy of Sciences, Beijing, CHINA
3Beijing ZhongkeJianlan Biotechnology Co., Ltd.; Beijing, CHINA
4Zhongke Jianlan International Medical Research Institute, Melbourne, Victoria, AUSTRALIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dexi Zhang
Fanjing Fan
2Institute of Biophysics, Chinese Academy of Sciences, Beijing, CHINA
3Beijing ZhongkeJianlan Biotechnology Co., Ltd.; Beijing, CHINA
4Zhongke Jianlan International Medical Research Institute, Melbourne, Victoria, AUSTRALIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baojun Wang
7Beijing Kewei Clinical Diagnostic Reagent Inc., Beijing, CHINA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Sáez-Llorens
8CEVAXIN, Centro de Vacunación e Investigación Panama Clinic, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xavier Sáez-Llorens
Rodrigo DeAntonio
8CEVAXIN, Centro de Vacunación e Investigación Panama Clinic, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rodrigo DeAntonio
Ivonne Torres-Atencio
9Facultad de Medicina, Universidad de Panamá, Panama City, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivonne Torres-Atencio
Eduardo Ortega-Barria
10GlaxoSmithKline Vaccines, City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo Ortega-Barria
Rao Kosagisharaf
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rao Kosagisharaf
Ricardo Lleonart
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo Lleonart
Li Chong
2Institute of Biophysics, Chinese Academy of Sciences, Beijing, CHINA
3Beijing ZhongkeJianlan Biotechnology Co., Ltd.; Beijing, CHINA
4Zhongke Jianlan International Medical Research Institute, Melbourne, Victoria, AUSTRALIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: agoodridge@indicasat.org.pa lichong@ibp.ac.cn
Amador Goodridge
1Centro de Biología Celular y Molecular de las Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amador Goodridge
  • For correspondence: agoodridge@indicasat.org.pa lichong@ibp.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in eight months. The serological detection of antibodies against the virus will play a pivotal role in complementing molecular tests to improve diagnostic accuracy, contact tracing, vaccine efficacy testing and seroprevalence surveillance. Here, we aimed first to evaluate a lateral flow assay’s ability to identify specific IgM and IgG antibodies against SARS-CoV-2 and second, to report the seroprevalence of these antibodies among health care workers and healthy volunteer blood donors in Panama. We recruited study participants between April 30th and July 7th, 2020. For the test validation and performance evaluation, we analyzed serum samples from participants with clinical symptoms and confirmed positive RT-PCR for SARS-CoV-2, participants with other confirmed infectious diseases, and a set of pre-pandemic serum samples. We used two by two table analysis to determine the test sensitivity and specificity as well as the kappa agreement value with a 95% confidence interval. Then, we used the lateral flow assay to determine seroprevalence among serum samples from COVID-19 patients, potentially exposed health care workers, and healthy volunteer donors. Our results show this assay reached a positive percent agreement of 97.2% (95% CI 84.2-100.0%) for detecting both IgM and IgG. The assay showed a kappa of 0.898 (95%CI 0.811-0.985) and 0.918 (95% CI 0.839-0.997) for IgM and IgG, respectively. The evaluation of serum samples from hospitalized COVID-19 patients indicates a correlation between test sensitivity and the number of days since symptom onset; the highest positive percent agreement (87% (95% CI 67.0-96.3%)) was observed at ≥15 days post-symptom onset. We found an overall antibody seroprevalence of 11.6% (95% CI 8.5-15.8%) among both health care workers and healthy blood donors. Our findings suggest this lateral flow assay could contribute significantly to implementing seroprevalence testing in locations with active community transmission of SARS-CoV-2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by Panama Secretaria Nacional de Ciencia Tecnologia e Innovacion (SENACYT) Rapid Grant No. COVID19-233 and Sistema Nacional de Investigacion (SNI). Additional support for personnel and field personnel was obtained from INDICASAT-AIP; a donation of commercial ELISA diagnosis kits was provided by the Club Rotario Panama Norte; the rapid test was donated by the Chinese Academy of Science; and the Key Research and Development Project of Hebei Province, China (20277705D) provided funding to Dr. Chong Li.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Comite Nacional de Bioetica de la Investigacion de Panama (CBNI) approval EC-CNBI-2020-03-43.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • COAUTHORS OF COVID-19 SEROLOGY COLLABORATOR GROUP:

    Julio Flores-Cuadra1, Jean-Paul Carrera5, Aron Benzadon11, Laiss Mudarra12, Lineth López13, Walter Valverde12, Fernando Díaz13, Isabel Blanco13, Nicolás Hurtado14, Neyla Rivas14, Odemaris Luque14, Julio Jurado14, David Cortez15

  • AFILIATIONS OF COVID-19 SEROLOGY COLLABORATOR GROUP

    1Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, PANAMA

    6Department of Research in Virology and Biotechnology, Gorgas Memorial Institute of Health Studies, Panama, PANAMA

    11Centro Medico Paitilla, Panama City, PANAMA

    12Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid, Caja de Seguro Social, Panama City, PANAMA

    13Hospital Punta Pacífica, Panama City, PANAMA

    14Compleo Hospitalario Manuel Amador Guerrero, Caja de Seguro Social, Colón City, PANAMÁ

    15Dirección Nacional de Laboratorios Clínicos, Ministerio de Salud, Panama City, PANAMA

Data Availability

All data will be available upon request by email to agoodridge{at}indicasat.org.pa

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 25, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama
Alcibiades Villarreal, Giselle Rangel, Xu Zhang, Digna Wong, Gabrielle Britton, Patricia L. Fernandez, Ambar Pérez, Diana Oviedo, Carlos Restrepo, María B. Carreirra, Dilcia Sambrano, Gilberto Eskildsen, Carolina De La Guardia, Yamitzel Zaldivar, Danilo Franco, Sandra López-Vergès, Dexi Zhang, Fanjing Fan, Baojun Wang, Xavier Sáez-Llorens, Rodrigo DeAntonio, Ivonne Torres-Atencio, Eduardo Ortega-Barria, Rao Kosagisharaf, Ricardo Lleonart, Li Chong, Amador Goodridge, COVID-19 serology collaborator group
medRxiv 2020.09.25.20201459; doi: https://doi.org/10.1101/2020.09.25.20201459
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Performance of a point of care test for detecting IgM and IgG antibodies against SARS-CoV-2 and seroprevalence in blood donors and health care workers in Panama
Alcibiades Villarreal, Giselle Rangel, Xu Zhang, Digna Wong, Gabrielle Britton, Patricia L. Fernandez, Ambar Pérez, Diana Oviedo, Carlos Restrepo, María B. Carreirra, Dilcia Sambrano, Gilberto Eskildsen, Carolina De La Guardia, Yamitzel Zaldivar, Danilo Franco, Sandra López-Vergès, Dexi Zhang, Fanjing Fan, Baojun Wang, Xavier Sáez-Llorens, Rodrigo DeAntonio, Ivonne Torres-Atencio, Eduardo Ortega-Barria, Rao Kosagisharaf, Ricardo Lleonart, Li Chong, Amador Goodridge, COVID-19 serology collaborator group
medRxiv 2020.09.25.20201459; doi: https://doi.org/10.1101/2020.09.25.20201459

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5273)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5895)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2023)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)